Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership $9.08 -0.34 (-3.61%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.64%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$504,129.74 Get ENTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENTA Insider Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Enanta Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/15/2024Scott T RottinghausInsiderSell5,375$17.08$91,805.00 7/11/2024Scott T RottinghausInsiderSell4,299$15.07$64,785.93 6/17/2024Tara Lynn KiefferInsiderSell7,266$12.33$89,589.78 12/13/2023Terry VanceDirectorSell15,295$9.12$139,490.40 12/5/2023Brendan LuuVPSell2,125$9.63$20,463.75 12/5/2023Jay R LulyCEOSell7,230$9.63$69,624.90 12/5/2023Paul J MellettCFOSell2,412$9.63$23,227.56 12/5/2023Scott T RottinghausCMOSell534$9.63$5,142.42 (Data available from 1/1/2013 forward) ENTA Insider Trading Activity - Frequently Asked Questions Who is on Enanta Pharmaceuticals's Insider Roster? The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Bruce L A Carter, Jay R Luly, Nathalie Adda, Paul J Mellett, Scott T Rottinghaus, Tara Lynn Kieffer, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA. What percentage of Enanta Pharmaceuticals stock is owned by insiders? 13.64% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings. Which Enanta Pharmaceuticals insiders have been selling company stock? The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($2,671,730.82), Paul J Mellett ($755,876.76), Scott T Rottinghaus ($161,733.35), Tara Lynn Kieffer ($89,589.78), Terry Vance ($139,490.40), and Yat Sun Or ($618,966.25). How much insider selling is happening at Enanta Pharmaceuticals? Insiders have sold a total of 131,813 Enanta Pharmaceuticals shares in the last 24 months for a total of $4,457,851.11 sold. Enanta Pharmaceuticals Key ExecutivesDr. Jay R. Luly Ph.D. (Age 68)President, CEO & Director Compensation: $1.25MMr. Paul J. Mellett Jr. (Age 69)Chief Financial & Administrative Officer Compensation: $666.84kDr. Yat Sun Or Ph.D. (Age 72)Senior VP of Research & Development and Chief Scientific Officer Compensation: $729.31kMr. Nathaniel S. Gardiner J.D. (Age 70)Consultant Compensation: $672.67kMr. Brendan Luu (Age 49)Chief Business Officer Compensation: $622.86kMs. Jennifer VieraSenior Director of Investor Relations & Corporate CommunicationsMr. Matthew P. Kowalsky J.D. (Age 51)Chief Legal Officer Ms. Tara Lynn Kieffer Ph.D. (Age 46)Chief Product Strategy Officer Compensation: $496.85k1 recent tradesDr. Scott T. Rottinghaus M.D. (Age 50)Senior VP & Chief Medical Officer Compensation: $616.73k2 recent trades More Insider Trading Tools from MarketBeat Related Companies ERAS Insider Trading EOLS Insider Trading PLRX Insider Trading CRON Insider Trading CGEM Insider Trading PRTA Insider Trading REPL Insider Trading CRGX Insider Trading AVXL Insider Trading CRMD Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ENTA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENTA Stock Alerts